B-type natriuretic peptide (BNP) predicts 90-day mortality and need for paracentesis in cirrhotic patients without systolic heart failure

Fluid overload is a common complication in patients with cirrhosis. B-type natriuretic peptide (BNP) is a marker of increased blood volume, commonly used in heart failure, that has been shown to be elevated in patients with liver disease. This study examined if BNP levels can be used to determine pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Araujo, Tiago, Vohra, Ishaan, Palacios, Pedro, Katiyar, Vatsala, Flores, Estefania, Randhawa, Tejinder, Wang, Yuchen, Abu-Omar, Yazan, Mukthinuthalapati, Vijaya, Mutneja, Hemant, Patel, Sanjay A., Attar, Bashar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814042/
https://www.ncbi.nlm.nih.gov/pubmed/33462246
http://dx.doi.org/10.1038/s41598-020-78946-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814042/
https://www.ncbi.nlm.nih.gov/pubmed/33462246
http://dx.doi.org/10.1038/s41598-020-78946-3

Ejemplares similares